Global Rasagiline Tablet Market Research Report 2023

Global Rasagiline Tablet Market Research Report 2023

Table of Contents
1 Rasagiline Tablet Market Overview
1.1 Product Overview and Scope of Rasagiline Tablet
1.2 Rasagiline Tablet Segment by Type
1.2.1 Global Rasagiline Tablet Market Value Comparison by Type (2023-2029)
1.2.2 0.5 mg/Pcs
1.2.3 1 mg/Pcs
1.3 Rasagiline Tablet Segment by Application
1.3.1 Global Rasagiline Tablet Market Value by Application: (2023-2029)
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Global Rasagiline Tablet Market Size Estimates and Forecasts
1.4.1 Global Rasagiline Tablet Revenue 2018-2029
1.4.2 Global Rasagiline Tablet Sales 2018-2029
1.4.3 Global Rasagiline Tablet Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Rasagiline Tablet Market Competition by Manufacturers
2.1 Global Rasagiline Tablet Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rasagiline Tablet Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rasagiline Tablet Average Price by Manufacturers (2018-2023)
2.4 Global Rasagiline Tablet Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Rasagiline Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rasagiline Tablet, Product Type & Application
2.7 Rasagiline Tablet Market Competitive Situation and Trends
2.7.1 Rasagiline Tablet Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rasagiline Tablet Players Market Share by Revenue
2.7.3 Global Rasagiline Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rasagiline Tablet Retrospective Market Scenario by Region
3.1 Global Rasagiline Tablet Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rasagiline Tablet Global Rasagiline Tablet Sales by Region: 2018-2029
3.2.1 Global Rasagiline Tablet Sales by Region: 2018-2023
3.2.2 Global Rasagiline Tablet Sales by Region: 2024-2029
3.3 Global Rasagiline Tablet Global Rasagiline Tablet Revenue by Region: 2018-2029
3.3.1 Global Rasagiline Tablet Revenue by Region: 2018-2023
3.3.2 Global Rasagiline Tablet Revenue by Region: 2024-2029
3.4 North America Rasagiline Tablet Market Facts & Figures by Country
3.4.1 North America Rasagiline Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rasagiline Tablet Sales by Country (2018-2029)
3.4.3 North America Rasagiline Tablet Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rasagiline Tablet Market Facts & Figures by Country
3.5.1 Europe Rasagiline Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rasagiline Tablet Sales by Country (2018-2029)
3.5.3 Europe Rasagiline Tablet Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rasagiline Tablet Market Facts & Figures by Country
3.6.1 Asia Pacific Rasagiline Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rasagiline Tablet Sales by Country (2018-2029)
3.6.3 Asia Pacific Rasagiline Tablet Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rasagiline Tablet Market Facts & Figures by Country
3.7.1 Latin America Rasagiline Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rasagiline Tablet Sales by Country (2018-2029)
3.7.3 Latin America Rasagiline Tablet Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rasagiline Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Rasagiline Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rasagiline Tablet Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rasagiline Tablet Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rasagiline Tablet Sales by Type (2018-2029)
4.1.1 Global Rasagiline Tablet Sales by Type (2018-2023)
4.1.2 Global Rasagiline Tablet Sales by Type (2024-2029)
4.1.3 Global Rasagiline Tablet Sales Market Share by Type (2018-2029)
4.2 Global Rasagiline Tablet Revenue by Type (2018-2029)
4.2.1 Global Rasagiline Tablet Revenue by Type (2018-2023)
4.2.2 Global Rasagiline Tablet Revenue by Type (2024-2029)
4.2.3 Global Rasagiline Tablet Revenue Market Share by Type (2018-2029)
4.3 Global Rasagiline Tablet Price by Type (2018-2029)
5 Segment by Application
5.1 Global Rasagiline Tablet Sales by Application (2018-2029)
5.1.1 Global Rasagiline Tablet Sales by Application (2018-2023)
5.1.2 Global Rasagiline Tablet Sales by Application (2024-2029)
5.1.3 Global Rasagiline Tablet Sales Market Share by Application (2018-2029)
5.2 Global Rasagiline Tablet Revenue by Application (2018-2029)
5.2.1 Global Rasagiline Tablet Revenue by Application (2018-2023)
5.2.2 Global Rasagiline Tablet Revenue by Application (2024-2029)
5.2.3 Global Rasagiline Tablet Revenue Market Share by Application (2018-2029)
5.3 Global Rasagiline Tablet Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Teva Pharmaceutical
6.1.1 Teva Pharmaceutical Corporation Information
6.1.2 Teva Pharmaceutical Description and Business Overview
6.1.3 Teva Pharmaceutical Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Pharmaceutical Rasagiline Tablet Product Portfolio
6.1.5 Teva Pharmaceutical Recent Developments/Updates
6.2 Lundbeck
6.2.1 Lundbeck Corporation Information
6.2.2 Lundbeck Description and Business Overview
6.2.3 Lundbeck Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Lundbeck Rasagiline Tablet Product Portfolio
6.2.5 Lundbeck Recent Developments/Updates
6.3 Sun Pharmaceutical
6.3.1 Sun Pharmaceutical Corporation Information
6.3.2 Sun Pharmaceutical Description and Business Overview
6.3.3 Sun Pharmaceutical Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sun Pharmaceutical Rasagiline Tablet Product Portfolio
6.3.5 Sun Pharmaceutical Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Apotex Rasagiline Tablet Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Taj Pharma
6.5.1 Taj Pharma Corporation Information
6.5.2 Taj Pharma Description and Business Overview
6.5.3 Taj Pharma Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Taj Pharma Rasagiline Tablet Product Portfolio
6.5.5 Taj Pharma Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Mylan Rasagiline Tablet Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Takeda Pharmaceutical
6.6.1 Takeda Pharmaceutical Corporation Information
6.6.2 Takeda Pharmaceutical Description and Business Overview
6.6.3 Takeda Pharmaceutical Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Takeda Pharmaceutical Rasagiline Tablet Product Portfolio
6.7.5 Takeda Pharmaceutical Recent Developments/Updates
6.8 Sandoz
6.8.1 Sandoz Corporation Information
6.8.2 Sandoz Description and Business Overview
6.8.3 Sandoz Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sandoz Rasagiline Tablet Product Portfolio
6.8.5 Sandoz Recent Developments/Updates
6.9 Intas Pharmaceuticals
6.9.1 Intas Pharmaceuticals Corporation Information
6.9.2 Intas Pharmaceuticals Description and Business Overview
6.9.3 Intas Pharmaceuticals Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Intas Pharmaceuticals Rasagiline Tablet Product Portfolio
6.9.5 Intas Pharmaceuticals Recent Developments/Updates
6.10 Natco Pharma
6.10.1 Natco Pharma Corporation Information
6.10.2 Natco Pharma Description and Business Overview
6.10.3 Natco Pharma Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Natco Pharma Rasagiline Tablet Product Portfolio
6.10.5 Natco Pharma Recent Developments/Updates
6.11 Ajanta Pharma
6.11.1 Ajanta Pharma Corporation Information
6.11.2 Ajanta Pharma Rasagiline Tablet Description and Business Overview
6.11.3 Ajanta Pharma Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Ajanta Pharma Rasagiline Tablet Product Portfolio
6.11.5 Ajanta Pharma Recent Developments/Updates
6.12 Orchid Pharma
6.12.1 Orchid Pharma Corporation Information
6.12.2 Orchid Pharma Rasagiline Tablet Description and Business Overview
6.12.3 Orchid Pharma Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Orchid Pharma Rasagiline Tablet Product Portfolio
6.12.5 Orchid Pharma Recent Developments/Updates
6.13 Alkem Laboratories
6.13.1 Alkem Laboratories Corporation Information
6.13.2 Alkem Laboratories Rasagiline Tablet Description and Business Overview
6.13.3 Alkem Laboratories Rasagiline Tablet Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Alkem Laboratories Rasagiline Tablet Product Portfolio
6.13.5 Alkem Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rasagiline Tablet Industry Chain Analysis
7.2 Rasagiline Tablet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rasagiline Tablet Production Mode & Process
7.4 Rasagiline Tablet Sales and Marketing
7.4.1 Rasagiline Tablet Sales Channels
7.4.2 Rasagiline Tablet Distributors
7.5 Rasagiline Tablet Customers
8 Rasagiline Tablet Market Dynamics
8.1 Rasagiline Tablet Industry Trends
8.2 Rasagiline Tablet Market Drivers
8.3 Rasagiline Tablet Market Challenges
8.4 Rasagiline Tablet Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Rasagiline Tablet Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Rasagiline Tablet Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Rasagiline Tablet Market Competitive Situation by Manufacturers in 2022
Table 4. Global Rasagiline Tablet Sales (M Pcs) of Key Manufacturers (2018-2023)
Table 5. Global Rasagiline Tablet Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Rasagiline Tablet Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Rasagiline Tablet Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Rasagiline Tablet Average Price (USD/K Pcs) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Rasagiline Tablet, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Rasagiline Tablet, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rasagiline Tablet, Product Type & Application
Table 12. Global Key Manufacturers of Rasagiline Tablet, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rasagiline Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rasagiline Tablet as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rasagiline Tablet Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Rasagiline Tablet Sales by Region (2018-2023) & (M Pcs)
Table 18. Global Rasagiline Tablet Sales Market Share by Region (2018-2023)
Table 19. Global Rasagiline Tablet Sales by Region (2024-2029) & (M Pcs)
Table 20. Global Rasagiline Tablet Sales Market Share by Region (2024-2029)
Table 21. Global Rasagiline Tablet Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Rasagiline Tablet Revenue Market Share by Region (2018-2023)
Table 23. Global Rasagiline Tablet Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Rasagiline Tablet Revenue Market Share by Region (2024-2029)
Table 25. North America Rasagiline Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 27. North America Rasagiline Tablet Sales by Country (2024-2029) & (M Pcs)
Table 28. North America Rasagiline Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Rasagiline Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Rasagiline Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 32. Europe Rasagiline Tablet Sales by Country (2024-2029) & (M Pcs)
Table 33. Europe Rasagiline Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Rasagiline Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Rasagiline Tablet Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Rasagiline Tablet Sales by Region (2018-2023) & (M Pcs)
Table 37. Asia Pacific Rasagiline Tablet Sales by Region (2024-2029) & (M Pcs)
Table 38. Asia Pacific Rasagiline Tablet Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Rasagiline Tablet Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Rasagiline Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 42. Latin America Rasagiline Tablet Sales by Country (2024-2029) & (M Pcs)
Table 43. Latin America Rasagiline Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Rasagiline Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Rasagiline Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 47. Middle East & Africa Rasagiline Tablet Sales by Country (2024-2029) & (M Pcs)
Table 48. Middle East & Africa Rasagiline Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Rasagiline Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Rasagiline Tablet Sales (M Pcs) by Type (2018-2023)
Table 51. Global Rasagiline Tablet Sales (M Pcs) by Type (2024-2029)
Table 52. Global Rasagiline Tablet Sales Market Share by Type (2018-2023)
Table 53. Global Rasagiline Tablet Sales Market Share by Type (2024-2029)
Table 54. Global Rasagiline Tablet Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Rasagiline Tablet Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Rasagiline Tablet Revenue Market Share by Type (2018-2023)
Table 57. Global Rasagiline Tablet Revenue Market Share by Type (2024-2029)
Table 58. Global Rasagiline Tablet Price (USD/K Pcs) by Type (2018-2023)
Table 59. Global Rasagiline Tablet Price (USD/K Pcs) by Type (2024-2029)
Table 60. Global Rasagiline Tablet Sales (M Pcs) by Application (2018-2023)
Table 61. Global Rasagiline Tablet Sales (M Pcs) by Application (2024-2029)
Table 62. Global Rasagiline Tablet Sales Market Share by Application (2018-2023)
Table 63. Global Rasagiline Tablet Sales Market Share by Application (2024-2029)
Table 64. Global Rasagiline Tablet Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Rasagiline Tablet Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Rasagiline Tablet Revenue Market Share by Application (2018-2023)
Table 67. Global Rasagiline Tablet Revenue Market Share by Application (2024-2029)
Table 68. Global Rasagiline Tablet Price (USD/K Pcs) by Application (2018-2023)
Table 69. Global Rasagiline Tablet Price (USD/K Pcs) by Application (2024-2029)
Table 70. Teva Pharmaceutical Corporation Information
Table 71. Teva Pharmaceutical Description and Business Overview
Table 72. Teva Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 73. Teva Pharmaceutical Rasagiline Tablet Product
Table 74. Teva Pharmaceutical Recent Developments/Updates
Table 75. Lundbeck Corporation Information
Table 76. Lundbeck Description and Business Overview
Table 77. Lundbeck Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 78. Lundbeck Rasagiline Tablet Product
Table 79. Lundbeck Recent Developments/Updates
Table 80. Sun Pharmaceutical Corporation Information
Table 81. Sun Pharmaceutical Description and Business Overview
Table 82. Sun Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 83. Sun Pharmaceutical Rasagiline Tablet Product
Table 84. Sun Pharmaceutical Recent Developments/Updates
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 88. Apotex Rasagiline Tablet Product
Table 89. Apotex Recent Developments/Updates
Table 90. Taj Pharma Corporation Information
Table 91. Taj Pharma Description and Business Overview
Table 92. Taj Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 93. Taj Pharma Rasagiline Tablet Product
Table 94. Taj Pharma Recent Developments/Updates
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 98. Mylan Rasagiline Tablet Product
Table 99. Mylan Recent Developments/Updates
Table 100. Takeda Pharmaceutical Corporation Information
Table 101. Takeda Pharmaceutical Description and Business Overview
Table 102. Takeda Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 103. Takeda Pharmaceutical Rasagiline Tablet Product
Table 104. Takeda Pharmaceutical Recent Developments/Updates
Table 105. Sandoz Corporation Information
Table 106. Sandoz Description and Business Overview
Table 107. Sandoz Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 108. Sandoz Rasagiline Tablet Product
Table 109. Sandoz Recent Developments/Updates
Table 110. Intas Pharmaceuticals Corporation Information
Table 111. Intas Pharmaceuticals Description and Business Overview
Table 112. Intas Pharmaceuticals Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 113. Intas Pharmaceuticals Rasagiline Tablet Product
Table 114. Intas Pharmaceuticals Recent Developments/Updates
Table 115. Natco Pharma Corporation Information
Table 116. Natco Pharma Description and Business Overview
Table 117. Natco Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 118. Natco Pharma Rasagiline Tablet Product
Table 119. Natco Pharma Recent Developments/Updates
Table 120. Ajanta Pharma Corporation Information
Table 121. Ajanta Pharma Description and Business Overview
Table 122. Ajanta Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 123. Ajanta Pharma Rasagiline Tablet Product
Table 124. Ajanta Pharma Recent Developments/Updates
Table 125. Orchid Pharma Corporation Information
Table 126. Orchid Pharma Description and Business Overview
Table 127. Orchid Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 128. Orchid Pharma Rasagiline Tablet Product
Table 129. Orchid Pharma Recent Developments/Updates
Table 130. Alkem Laboratories Corporation Information
Table 131. Alkem Laboratories Description and Business Overview
Table 132. Alkem Laboratories Rasagiline Tablet Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 133. Alkem Laboratories Rasagiline Tablet Product
Table 134. Alkem Laboratories Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Rasagiline Tablet Distributors List
Table 138. Rasagiline Tablet Customers List
Table 139. Rasagiline Tablet Market Trends
Table 140. Rasagiline Tablet Market Drivers
Table 141. Rasagiline Tablet Market Challenges
Table 142. Rasagiline Tablet Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rasagiline Tablet
Figure 2. Global Rasagiline Tablet Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Rasagiline Tablet Market Share by Type in 2022 & 2029
Figure 4. 0.5 mg/Pcs Product Picture
Figure 5. 1 mg/Pcs Product Picture
Figure 6. Global Rasagiline Tablet Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Rasagiline Tablet Market Share by Application in 2022 & 2029
Figure 8. Under 40 Years Old
Figure 9. 40-65 Years Old
Figure 10. Above 65 Years Old
Figure 11. Global Rasagiline Tablet Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Rasagiline Tablet Market Size (2018-2029) & (US$ Million)
Figure 13. Global Rasagiline Tablet Sales (2018-2029) & (M Pcs)
Figure 14. Global Rasagiline Tablet Average Price (USD/K Pcs) & (2018-2029)
Figure 15. Rasagiline Tablet Report Years Considered
Figure 16. Rasagiline Tablet Sales Share by Manufacturers in 2022
Figure 17. Global Rasagiline Tablet Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Rasagiline Tablet Players: Market Share by Revenue in 2022
Figure 19. Rasagiline Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Rasagiline Tablet Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Rasagiline Tablet Sales Market Share by Country (2018-2029)
Figure 22. North America Rasagiline Tablet Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Rasagiline Tablet Sales Market Share by Country (2018-2029)
Figure 26. Europe Rasagiline Tablet Revenue Market Share by Country (2018-2029)
Figure 27. Germany Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Rasagiline Tablet Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Rasagiline Tablet Revenue Market Share by Region (2018-2029)
Figure 34. China Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Rasagiline Tablet Sales Market Share by Country (2018-2029)
Figure 44. Latin America Rasagiline Tablet Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Rasagiline Tablet Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Rasagiline Tablet Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Rasagiline Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Rasagiline Tablet by Type (2018-2029)
Figure 54. Global Revenue Market Share of Rasagiline Tablet by Type (2018-2029)
Figure 55. Global Rasagiline Tablet Price (USD/K Pcs) by Type (2018-2029)
Figure 56. Global Sales Market Share of Rasagiline Tablet by Application (2018-2029)
Figure 57. Global Revenue Market Share of Rasagiline Tablet by Application (2018-2029)
Figure 58. Global Rasagiline Tablet Price (USD/K Pcs) by Application (2018-2029)
Figure 59. Rasagiline Tablet Value Chain
Figure 60. Rasagiline Tablet Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs